Related Experiment Videos
Summary
Topical corticosteroids are effective for managing chronic rhinosinusitis with nasal polyps (CRSwNP), offering local anti-inflammatory benefits with minimal systemic side effects. Alternative therapies like macrolides and verapamil show promise for steroid-resistant cases.
Area of Science:
- Otolaryngology
- Immunology
- Pharmacology
Background:
- Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex inflammatory disease with varied causes.
- Current management relies on anti-inflammatory agents, with corticosteroids being the most common.
Purpose of the Study:
- To review the role and efficacy of topical corticosteroids in managing CRSwNP.
- To discuss alternative and adjunctive therapies for steroid-resistant or specific CRSwNP phenotypes.
Main Methods:
- Review of existing literature on CRSwNP management strategies.
- Analysis of corticosteroid efficacy, safety, and alternative treatments like anti-IL5, macrolides, and verapamil.
Main Results:
- Topical corticosteroids provide effective local anti-inflammatory action with minimal systemic absorption and side effects, especially post-surgery.
- Patients with eosinophilic CRSwNP often respond well to corticosteroids.
- Macrolides may benefit neutrophilic CRSwNP, and verapamil shows potential for steroid-resistant cases.
Conclusions:
- Topical corticosteroids are crucial for long-term CRSwNP management, offering localized control with a favorable safety profile.
- Understanding CRSwNP pathophysiology guides the selection of appropriate anti-inflammatory and immunomodulatory therapies.